{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T20:47:08Z","timestamp":1772052428291,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T00:00:00Z","timestamp":1680220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T00:00:00Z","timestamp":1680220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["22K08991"],"award-info":[{"award-number":["22K08991"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We assessed the prognostic value of five complex inflammatory and nutritional parameters, namely neutrophil-to-lymphocyte ratio (NLR), prognostic nutritional index (PNI), C-reactive protein-to-NLR ratio (C\/NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-to-monocyte ratio (LMR) using data from patients with malignant pleural mesothelioma (MPM) undergoing extrapleural pneumonectomy (EPP). Moreover, the correlation between these five parameters and programmed cell death protein 1 ligand-1 (PD-L1) expression in the tumor microenvironment was evaluated. This study included consecutive MPM patients who underwent EPP. The histological subtype of the eligible patients (n\u2009=\u200961) correlated with all five parameters. Moreover, the PD-L1 expression scores for immune cells correlated with NLR and PLR, and the PD-L1 expression scores for both tumor cells and immune cells were inversely correlated with both PNI and LMR. Univariate analysis elucidated that NLR, PNI, and C\/NLR were predictors of 5-year overall survival (OS), and multivariate analysis revealed that NLR was an independent predictor of 5-year OS, suggesting that NLR is a preoperative, prognostic factor for patients with MPM who are scheduled for EPP. To the best of our knowledge, this is the first study to evaluate the prognostic potentials of NLR, PNI, C\/NLR, PLR, and LMR simultaneously in patients with MPM who underwent EPP.<\/jats:p>","DOI":"10.1038\/s41598-023-31448-4","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T10:02:54Z","timestamp":1680256974000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Preoperative neutrophil-to-lymphocyte ratio correlates with PD-L1 expression in immune cells of patients with malignant pleural mesothelioma and predicts prognosis"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1343-1275","authenticated-orcid":false,"given":"Riki","family":"Okita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4340-0894","authenticated-orcid":false,"given":"Nobutaka","family":"Kawamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetoshi","family":"Inokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,31]]},"reference":[{"key":"31448_CR1","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1200\/JCO.2008.17.5604","volume":"27","author":"M de Perrot","year":"2009","unstructured":"de Perrot, M. et al. Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J. Clin. Oncol. 27, 1413\u20131418 (2009).","journal-title":"J. Clin. Oncol."},{"key":"31448_CR2","doi-asserted-by":"publisher","first-page":"5485","DOI":"10.1158\/1078-0432.CCR-19-0103","volume":"25","author":"M Okada","year":"2019","unstructured":"Okada, M. et al. Clinical efficacy and safety of nivolumab: Results of a multicenter, open-label, single-arm, Japanese phase II study in malignant pleural mesothelioma (MERIT). Clin. Cancer Res. 25, 5485\u20135492 (2019).","journal-title":"Clin. Cancer Res."},{"key":"31448_CR3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0140-6736(20)32714-8","volume":"397","author":"P Baas","year":"2021","unstructured":"Baas, P. et al. First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial. Lancet 397, 375\u2013386 (2021).","journal-title":"Lancet"},{"key":"31448_CR4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12957-015-0710-7","volume":"13","author":"K Shimizu","year":"2015","unstructured":"Shimizu, K. et al. Preoperative neutrophil\/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer. World J. Surg. Oncol. 13, 291 (2015).","journal-title":"World J. Surg. Oncol."},{"key":"31448_CR5","doi-asserted-by":"publisher","first-page":"4138","DOI":"10.1245\/s10434-015-4516-1","volume":"22","author":"AW Chan","year":"2015","unstructured":"Chan, A. W. et al. Prognostic nutritional index (PNI) predicts tumor recurrence of very early\/early stage hepatocellular carcinoma after surgical resection. Ann. Surg. Oncol. 22, 4138\u20134148 (2015).","journal-title":"Ann. Surg. Oncol."},{"key":"31448_CR6","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1245\/s10434-015-4948-7","volume":"23","author":"M Ishizuka","year":"2016","unstructured":"Ishizuka, M. et al. Clinical significance of the C-reactive protein to albumin ratio for survival after surgery for colorectal cancer. Ann. Surg. Oncol. 23, 900\u2013907 (2016).","journal-title":"Ann. Surg. Oncol."},{"key":"31448_CR7","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/JTO.0b013e31823f45c1","volume":"7","author":"DJ Pinato","year":"2012","unstructured":"Pinato, D. J. et al. Inflammation-based prognostic indices in malignant pleural mesothelioma. J. Thorac. Oncol. 7, 587\u2013594 (2012).","journal-title":"J. Thorac. Oncol."},{"key":"31448_CR8","doi-asserted-by":"publisher","first-page":"101813","DOI":"10.1016\/j.suronc.2022.101813","volume":"43","author":"R Okita","year":"2022","unstructured":"Okita, R., Okada, M., Inokawa, H., Murakami, T. & Ikeda, E. Prognostic values of preoperative C-reactive protein, albumin, and neutrophil ratios in patients with malignant pleural mesothelioma who underwent extrapleural pneumonectomy. Surg. Oncol. 43, 101813 (2022).","journal-title":"Surg. Oncol."},{"key":"31448_CR9","doi-asserted-by":"publisher","first-page":"5805","DOI":"10.1158\/1078-0432.CCR-10-2245","volume":"16","author":"SC Kao","year":"2010","unstructured":"Kao, S. C. et al. High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clin. Cancer Res. 16, 5805\u20135813 (2010).","journal-title":"Clin. Cancer Res."},{"key":"31448_CR10","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1097\/JTO.0b013e31822a3740","volume":"6","author":"SC Kao","year":"2011","unstructured":"Kao, S. C. et al. Low calretinin expression and high neutrophil-to-lymphocyte ratio are poor prognostic factors in patients with malignant mesothelioma undergoing extrapleural pneumonectomy. J. Thorac. Onco. 6, 1923\u20131939 (2011).","journal-title":"J. Thorac. Onco."},{"key":"31448_CR11","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1007\/s00432-013-1523-0","volume":"139","author":"ZH Yao","year":"2013","unstructured":"Yao, Z. H. et al. Prognostic nutritional index predicts outcomes of malignant pleural mesothelioma. J. Cancer Res. Clin. Oncol. 139, 2117\u20132123 (2013).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"31448_CR12","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","volume":"192","author":"GJ Freeman","year":"2012","unstructured":"Freeman, G. J. et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192, 1027\u20131034 (2012).","journal-title":"J. Exp. Med."},{"key":"31448_CR13","doi-asserted-by":"publisher","first-page":"e0121071","DOI":"10.1371\/journal.pone.0121071","volume":"10","author":"S Cedres","year":"2015","unstructured":"Cedres, S. et al. Analysis of expression of programmed cell death 1 ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM). PLoS One 10, e0121071 (2015).","journal-title":"PLoS One"},{"key":"31448_CR14","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.jtho.2017.05.024","volume":"12","author":"SC Kao","year":"2017","unstructured":"Kao, S. C. et al. Tumor suppressor microRNAs contribute to the regulation of PD-L1 expression in malignant pleural mesothelioma. J. Thorac. Oncol. 12, 1421\u20131433 (2017).","journal-title":"J. Thorac. Oncol."},{"key":"31448_CR15","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.jtho.2017.02.013","volume":"12","author":"B Thapa","year":"2017","unstructured":"Thapa, B. et al. The immune microenvironment, genome-wide copy number aberrations, and survival in mesothelioma. J. Thorac. Oncol. 12, 850\u2013859 (2017).","journal-title":"J. Thorac. Oncol."},{"key":"31448_CR16","doi-asserted-by":"publisher","first-page":"20769","DOI":"10.18632\/oncotarget.25100","volume":"9","author":"T Watanabe","year":"2018","unstructured":"Watanabe, T. et al. Four immunohistochemical assays to measure the PD-L1 expression in malignant pleural mesothelioma. Oncotarget 9, 20769\u201320780 (2018).","journal-title":"Oncotarget"},{"key":"31448_CR17","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1016\/j.jtcvs.2019.10.122","volume":"159","author":"M de Perrot","year":"2020","unstructured":"de Perrot, M. et al. Prognostic influence of tumor microenvironment after hypofractionated radiation and surgery for mesothelioma. J. Thorac. Cardiovasc. Surg. 159, 2082-2091.e1 (2020).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"31448_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-022-03292-4","author":"R Okita","year":"2022","unstructured":"Okita, R. et al. Effects of tumor-infiltrating CD8+ T cells, PD1\/PD-L1 axis, and expression patterns of HLA class I on the prognosis of patients with malignant pleural mesothelioma who underwent extrapleural pneumonectomy. Cancer Immunol. Immunother. https:\/\/doi.org\/10.1007\/s00262-022-03292-4 (2022).","journal-title":"Cancer Immunol. Immunother."},{"key":"31448_CR19","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nm730","volume":"8","author":"H Dong","year":"2002","unstructured":"Dong, H. et al. Tumor-associated B7\u2013H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8, 793\u2013800 (2002).","journal-title":"Nat. Med."},{"key":"31448_CR20","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/1759-7714.13847","volume":"12","author":"R Okita","year":"2021","unstructured":"Okita, R., Shimizu, K., Nojima, Y., Saisho, S. & Nakata, M. Tofacitinib overcomes an IFN\u03b3-induced decrease in NK cell-mediated cytotoxicity via the regulation of immune-related molecules in LC-2\/ad. Thorac. Cancer 12, 775\u2013782 (2021).","journal-title":"Thorac. Cancer"},{"key":"31448_CR21","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3389\/fimmu.2018.01055","volume":"9","author":"Y Alwarawrah","year":"2018","unstructured":"Alwarawrah, Y., Kiernan, K. & MacIver, N. J. Changes in nutritional status impact immune cell metabolism and function. Front. Immunol. 9, 1055 (2018).","journal-title":"Front. Immunol."},{"key":"31448_CR22","first-page":"577","volume":"11","author":"O Najera","year":"2004","unstructured":"Najera, O., Gonzalez, C., Toledo, G., Lopez, L. & Ortiz, R. Flow cytometry study of lymphocyte subsets in malnourished and well-nourished children with bacterial infections. Clin. Diagn. Lab. Immunol. 11, 577\u2013580 (2004).","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"31448_CR23","volume-title":"WHO classification of tumours of the lung, pleura, thymus and heart","author":"Travis, W.D. International Agency for Research on C","year":"2015","unstructured":"Travis, W.D. International Agency for Research on C. WHO classification of tumours of the lung, pleura, thymus and heart (International Agency for Research on cancer, 2015)."},{"key":"31448_CR24","unstructured":"Nowak, A.K. et al. The IASLC Mesothelioma Staging Project: Proposals for revisions of the T descriptors in the forthcoming eighth edition of the TNM classification for pleural mesothelioma. J. Thorac. Oncol. 11, 2089\u20132099 (2016)."},{"key":"31448_CR25","unstructured":"Rice, D. et al. The IASLC Mesothelioma Staging Project: Proposals for revisions of the N descriptors in the forthcoming eighth Edition of the TNM Classification for pleural mesothelioma. J. Thorac. Oncol. 11, 2100\u20132111 (2016)."},{"key":"31448_CR26","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1016\/j.jtho.2016.09.124","volume":"11","author":"VW Rusch","year":"2016","unstructured":"Rusch, V. W. et al. The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for mesothelioma. J. Thorac. Oncol. 11, 2112\u20132119 (2016).","journal-title":"J. Thorac. Oncol."},{"key":"31448_CR27","first-page":"1001","volume":"85","author":"T Onodera","year":"1984","unstructured":"Onodera, T., Goseki, N. & Kosaki, G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi 85, 1001\u20131005 (1984).","journal-title":"Nihon Geka Gakkai Zasshi"},{"key":"31448_CR28","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/PAI.0000000000000594","volume":"27","author":"B Vennapusa","year":"2019","unstructured":"Vennapusa, B. et al. Development of a PD-L1 complementary diagnostic immunohistochemistry assay (SP142) for atezolizumab. Appl. Immunohistochem. Mol. Morphol. 27, 92\u2013100 (2019).","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"31448_CR29","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/S0003-4975(99)01038-3","volume":"68","author":"VW Rusch","year":"1999","unstructured":"Rusch, V. W. & Venkatraman, E. S. Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann. Thorac. Surg. 68, 1799\u20131804 (1999).","journal-title":"Ann. Thorac. Surg."},{"key":"31448_CR30","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1510\/icvts.2007.166322","volume":"7","author":"M Okada","year":"2008","unstructured":"Okada, M. et al. Radical surgery for malignant pleural mesothelioma: results and prognosis. Interact. Cardiovasc. Thorac. Surg. 7, 102\u2013106 (2008).","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"key":"31448_CR31","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.athoracsur.2014.05.071","volume":"98","author":"O Lauk","year":"2014","unstructured":"Lauk, O. et al. Extrapleural pneumonectomy after induction chemotherapy: perioperative outcome in 251 mesothelioma patients from three high-volume institutions. Ann. Thorac. Surg. 98, 1748\u20131754 (2014).","journal-title":"Ann. Thorac. Surg."},{"key":"31448_CR32","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/ijc.2910370619","volume":"37","author":"M Ishikawa","year":"1986","unstructured":"Ishikawa, M., Koga, Y., Hosokawa, M. & Kobayashi, H. Augmentation of B16 melanoma lung colony formation in C57BL\/6 mice having marked granulocytosis. Int. J. Cancer 37, 919\u2013924 (1986).","journal-title":"Int. J. Cancer"},{"key":"31448_CR33","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jtho.2015.10.003","volume":"11","author":"A Bille","year":"2016","unstructured":"Bille, A., Krug, L. M., Woo, K. M., Rusch, V. W. & Zauderer, M. G. Contemporary analysis of prognostic factors in patients with unresectable malignant pleural mesothelioma. J. Thorac. Oncol. 11, 249\u2013255 (2016).","journal-title":"J. Thorac. Oncol."},{"key":"31448_CR34","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1084\/jem.193.9.1005","volume":"193","author":"K Hattori","year":"2001","unstructured":"Hattori, K. et al. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J. Exp. Med. 193, 1005\u20131014 (2001).","journal-title":"J. Exp. Med."},{"key":"31448_CR35","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/path.824","volume":"193","author":"L Strizzi","year":"2001","unstructured":"Strizzi, L. et al. Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma. J. Pathol. 193, 468\u2013475 (2001).","journal-title":"J. Pathol."},{"key":"31448_CR36","first-page":"4140","volume":"55","author":"MR Freeman","year":"1995","unstructured":"Freeman, M. R. et al. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Cancer Res. 55, 4140\u20134145 (1995).","journal-title":"Cancer Res."},{"key":"31448_CR37","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/joim.12229","volume":"276","author":"Y Mao","year":"2014","unstructured":"Mao, Y., Poschke, I. & Kiessling, R. Tumour-induced immune suppression: role of inflammatory mediators released by myelomonocytic cells. J. Intern. Med. 276, 154\u2013170 (2014).","journal-title":"J. Intern. Med."},{"key":"31448_CR38","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/j.jtho.2019.03.029","volume":"14","author":"IC Salaroglio","year":"2019","unstructured":"Salaroglio, I. C. et al. Potential diagnostic and prognostic role of microenvironment in malignant pleural mesothelioma. J. Thorac. Oncol. 14, 1458\u20131471 (2019).","journal-title":"J. Thorac. Oncol."},{"key":"31448_CR39","doi-asserted-by":"crossref","unstructured":"Meyer, C. et al. Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model. Proc. Natl. Acad. Sci. U S A 108, 17111\u201317116 (2011).","DOI":"10.1073\/pnas.1108121108"},{"key":"31448_CR40","doi-asserted-by":"publisher","unstructured":"Bazhin, A.V. et al. Pivotal antitumor role of the immune checkpoint molecule B7-H1 in pancreatic cancer. Oncoimmunology 11, 2043037; https:\/\/doi.org\/10.1080\/2162402X.2022.2043037 (2022).","DOI":"10.1080\/2162402X.2022.2043037"},{"key":"31448_CR41","doi-asserted-by":"publisher","first-page":"342","DOI":"10.4161\/cbt.4.3.1644","volume":"4","author":"P DeLong","year":"2005","unstructured":"DeLong, P. et al. Regulatory T cells and cytokines in malignant pleural effusions secondary to mesothelioma and carcinoma. Cancer Biol. Ther. 4, 342\u2013346 (2005).","journal-title":"Cancer Biol. Ther."},{"key":"31448_CR42","first-page":"3590","volume":"51","author":"G Zugmaier","year":"1991","unstructured":"Zugmaier, G. et al. Transforming growth factor beta 1 induces cachexia and systemic fibrosis without an antitumor effect in nude mice. Cancer Res. 51, 3590\u20133594 (1991).","journal-title":"Cancer Res."},{"key":"31448_CR43","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.it.2016.04.003","volume":"37","author":"CD Bourke","year":"2016","unstructured":"Bourke, C. D., Berkley, J. A. & Prendergast, A. J. Immune dysfunction as a cause and consequence of malnutrition. Trends Immunol. 37, 386\u2013398 (2016).","journal-title":"Trends Immunol."},{"key":"31448_CR44","first-page":"1898","volume":"7","author":"T Tagawa","year":"2015","unstructured":"Tagawa, T. et al. Clinical role of a new prognostic score using platelet-to-lymphocyte ratio in patients with malignant pleural mesothelioma undergoing extrapleural pneumonectomy. J. Thorac Dis. 7, 1898\u20131906 (2015).","journal-title":"J. Thorac Dis."},{"key":"31448_CR45","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.lungcan.2015.07.014","volume":"90","author":"T Yamagishi","year":"2015","unstructured":"Yamagishi, T. et al. Prognostic significance of the lymphocyte-to-monocyte ratio in patients with malignant pleural mesothelioma. Lung Cancer 90, 111\u2013117 (2015).","journal-title":"Lung Cancer"},{"key":"31448_CR46","doi-asserted-by":"publisher","unstructured":"Qu, Z. et al. Preoperative prognostic nutritional index and neutrophil-to-lymphocyte ratio predict survival outcomes of patients with hepatocellular carcinoma after curative resection. Front. Oncol. 11, 823054; https:\/\/doi.org\/10.3389\/fonc.2021.823054 (2021).","DOI":"10.3389\/fonc.2021.823054"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31448-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31448-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31448-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T10:07:15Z","timestamp":1680257235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31448-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,31]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["31448"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-31448-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,31]]},"assertion":[{"value":"13 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5263"}}